<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>64x Bio — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>141. 64x Bio</h1>
    <p class="meta">Optimized Cell Lines for Gene Therapy Manufacturing</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>64x Bio</strong></p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Tell me more about this company's origin story...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Lex Rovner & George Church</strong></p><p>Wyss Institute / Harvard Medical School</p><p>Renowned geneticist George Church and Lex Rovner leveraging synthetic biology expertise</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Research the founder's background and credentials...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>3. Product Overview</h3><p>64x Bio develops optimized cell lines for gene therapy manufacturing using proprietary genome engineering technology. The company's platform enhances viral vector production yields by engineering producer cells with improved productivity, enabling more affordable and scalable gene therapy manufacturing for pharmaceutical partners.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What competitors does this product face?">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Series A</strong> — Raised $55M to advance cell line optimization platform for gene therapy manufacturing.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What's the typical next funding milestone?">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered through Wyss Institute spinout portfolio and George Church's gene therapy manufacturing innovation research.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Find more recent news about this company...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Manufacturing bottleneck solution:</strong> Gene therapy manufacturing capacity is a critical industry constraint.</li><li><strong>Scientific leadership:</strong> George Church's involvement provides unparalleled credibility in genome engineering.</li></ul>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Validate these strengths with market data...">
        <button>Ask AI</button>
      </div>
    </div>
    </div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>B2B dependency:</strong> Relies on pharma partnerships for revenue, long sales cycles.</li><li><strong>Technical complexity:</strong> Cell line engineering requires extensive validation for each therapeutic application.</li></ul>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What other risks should I consider?">
        <button>Ask AI</button>
      </div>
    </div>
    </div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>What yield improvements do your optimized cell lines achieve compared to standard producer cells?</li><li>How many pharmaceutical partnerships have you established to date?</li><li>What is your IP position around the cell line engineering platform?</li><li>How do you validate cell line safety and consistency for regulatory approval?</li><li>What is your manufacturing capacity roadmap and partnership strategy?</li></ol>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Generate additional due diligence questions...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section email-draft">
    <h3>8. Draft Outreach Email</h3>
    <div class="email-box">
      <p><strong>Subject:</strong> Harvard Undergraduate Capital Partners — Coffee Chat with 64x Bio?</p>
      <p>Hi Lex,</p>
      <p>I'm reaching out from <strong>Harvard Undergraduate Capital Partners (HUCP)</strong>, a student-run investment group at Harvard focused on early-stage ventures led by Harvard-affiliated founders.</p>
      <p>We've been following 64x Bio's work in optimizing cell lines for gene therapy manufacturing and are impressed by your $55M Series A raise and the platform's potential to solve critical manufacturing bottlenecks in the gene therapy industry. Given your Wyss Institute and Harvard Medical School affiliation alongside Dr. George Church, we'd love to learn more about your vision and explore how HUCP might support 64x Bio's growth.</p>
      <p>Would you be open to a 20-minute coffee chat or call in the coming weeks? We're flexible on timing and happy to work around your schedule.</p>
      <p>Looking forward to connecting.</p>
      <p>Best,<br>[Your Name]<br>Harvard Undergraduate Capital Partners</p>
    </div>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Personalize this email with more specific details...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
<script src="script.js?v=4"></script>
</body>
</html>
